La formulación magistral en la terapéutica dermatológica actual

Actas Dermo-Sifiliográficas - Tập 104 - Trang 738-756 - 2013
M. Sánchez-Regaña1, F. Llambí-Mateos2, M. Salleras-Redonnet1, M. Iglesias Sancho1, H. Collgros Totosaus1, P. Umbert-Millet1
1Servicio de Dermatología. Hospital Universitari Sagrat Cor. Barcelona. España
2Profesor UT Galénica, Facultad de Farmacia, Universidad de Barcelona, Presidente de APROFARM, Barcelona, España

Tài liệu tham khảo

2010, La formulación magistral: una opción de futuro en España, Farmacéuticos, 360, 52 USP Pharmacopeia. 35 ed. Monografía 795 Rockville, USA; 2011. Consejo de Europa. Resolución CM/ResAP (2011) 1. Exigencias relativas a la garantía de calidad y de inocuidad de los medicamentos preparados en las farmacias para las necesidades especiales de los pacientes. Estrasburgo, enero. Rockville:United States Pharmacopeia Convention Inc.: 2011. [consultado 23 feb 2012]. Disponible en: http://www.cofares.es/FileDownload.aspx?Key=FILES&Log=True&id=23601 2006, Ley 29/2006 sobre garantías y Uso racional del medicamento y productos sanitarios, BOE, 178 2001, Real Decreto 175/2001 sobre Normas de correcta elaboración y control de calidad en formulaciones magistrales y preparados oficinales, BOE, 65 Umbert, 2008, Aporte de la formulación a la terapéutica actual, 15 Llambí, 2011, Desabastecimientos, formulación y criterios sanitarios, El Farmacéutico, 11, 35 Llambí, 2008, Nuevos vehículos en formulación dermatología, 39 Llambí, 2009, Nuevos vehículos para formulación dermatológica, Piel, 24, 394, 10.1016/S0213-9251(09)72026-X Carrascosa, 2009, Tratamiento tópico de la psoriasis, Actas Dermosifiliogr, 100, 190, 10.1016/S0001-7310(09)70534-4 Feldman, 2006, General approach to psoriasis treatment, 3 Aizpún, 2010, La formulación magistral en Dermatología, hoy en día, Piel, 25, 291, 10.1016/j.piel.2010.04.006 Rim, 2005, Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients, Clin Exp Dermatol, 30, 409, 10.1111/j.1365-2230.2005.01773.x Lavker, 1992, Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid, J Am Acad Dermatol, 26, 535, 10.1016/0190-9622(92)70076-R Stüccker, 2001, Vitamin B12 cream containing avocado oil in the therapy of plaque psoriasis, Dermatology, 203, 141, 10.1159/000051729 Sánchez-Regaña, 2011, Topical vitamin B12: evaluation of its efficacy in plaque-type psoriasis, Revista Latinoamericana de Psoriasis y Artritis psoriásica, 3, 15 Martín-Ezquerra, 2006, Topical tacrolimus for the treatment of psoriasis of psoriasis of the face, genitalia, intertriginous areas and corporal plaques, J Drugs Dermatol, 5, 334 Vissers, 2008, Topical treatment of mild to moderate plaque psoriasis with 0,3% tacrolimus gel and 0,5% tacrolimus cream: the effects on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression, Br J Dermatol, 158, 705, 10.1111/j.1365-2133.2008.08442.x Zampetti, 2008, Topical preparation for the treatment of psoriasis: results of a retrospective study over 15 years, J Dermatolog Treat, 19, 134, 10.1080/09546630701846087 de Jarger, 2010, Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion, Dermatology, 220, 329, 10.1159/000278241 Chern, 2011, Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis, Acta Derm Venereol, 91, 447, 10.2340/00015555-1096 Liao, 2007, Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g (-1) ointment and tacrolimus 0,3 ug g (-1) oinment in chronic plaque psoriasis involging facial or genitofemoral areas: a double-blind randomized controlled trial, Br J Dermatol, 157, 1005, 10.1111/j.1365-2133.2007.08201.x Fischer, 2010, Psoriasis ungueal: tratamiento con ungüento de tazaroteno al 0,1% Eskicirak, 2006, The treatment of psoriasis vulgaris: 1% topical methotrexate gel, Int J Dermatol, 45, 965, 10.1111/j.1365-4632.2006.02911.x Sánchez-Regaña, 2002, Empleo de calcipotriol tópico en la psoriasis ungueal, Piel, 17, 104, 10.1016/S0213-9251(02)72549-5 Márquez, 2009, Tacalcitol ointment for the treatment of nail psoriasis, J Dermatolog Treat, 20, 308, 10.1080/09546630902787585 Sánchez-Regaña, 2005, Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients, J Eur Acad Dermatol Venereol, 19, 573, 10.1111/j.1468-3083.2005.01253.x Sánchez-Regaña, 2008, Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol oinment, J Eur Acad Dermatol Venereol, 22, 963, 10.1111/j.1468-3083.2008.02679.x Sánchez Regaña, 2008, Aspectos diagnósticos y terapéuticos de la psoriasis ungueal, Actas Dermosifiliogr, 99, 34, 10.1016/S0001-7310(08)74613-1 Sánchez Regaña, 2007, Prevalence of fungal involvement in a series of patients with nail psoriasis, Clin Exp Dermatol, 33, 194, 10.1111/j.1365-2230.2007.02568.x Sola, 2009, Psoriasis del cuero cabelludo, Actas Dermosifiliogr, 100, 536, 10.1016/S0001-7310(09)71901-5 Carrascosa, 2011, Documento de consenso de fototerapia en psoriasis del grupo español de psoriasis: UVBBE, láser, fuentes monocromáticas de excímeros y terapia fotodinámica, Actas Dermosifiliogr, 102, 175, 10.1016/j.ad.2010.11.002 Martin, 2007, Optimization of narrow-band UVB with 5% oleic acid cream in the treatment of psoriasis, J Drugs Dermatol, 6, 290 Sánchez-Regaña, 2008, Psoriasis, 157 Weiss, 2008, Long term safety and efficacy study of adapalene 0.3% gel, J Drugs Dermatol, 7, 24S Draelos, 2007, Two Randomized studies demonstrate the efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris, J Am Acad Dermatol, 56, 439, 10.1016/j.jaad.2006.10.005 Pazoki-Toroudi, 2010, Combination of azelaic acid 5% and erytromicin 2% in the treatment of acne vulgaris, J Dematol Treat, 21, 212, 10.3109/09546630903440064 Del Rosso, 2008, Clindamycin 1.2% and retinoid acid 0.025%: vehicle, stability and tolerability, Cutis, 81, 405 Webster, 2009, Efficacy and tolerability of a fixed combination of clindamycin phosphate (1,2%) and low concentration benzoyl peroxide (2,5%) aqueous gel in moderate or severe acne subpopulations, J Drugs Dermatol, 8, 736 Tanghetti, 2007, Tazarotene 0,1% cream plus clindamycin 1% versus tretinoin 0.025% plus clindamycin 1% gel in the treatment of facial acne vulgaris, Dermatol Online J, 13, 1, 10.5070/D30N81Z2H4 McElhiney, 2010, Developing a retinoid oral liquid for patients who cannot take capsules, Int J Pharmaceutical Compounding, 14, 118 Del Rosso, 2010, Efficacy of topical azelaic acid gel 15% plus oral doxixycline 40mg versus metronidazol gel 1% plus oral doxicycline 40mg in mild-to moderate papulopustular rosacea, J Drugs Dermatol, 9, 607 Gupta, 2007, Azelaic acid in the treatment of acne rosacea, Int J Dermatol, 46, 533, 10.1111/j.1365-4632.2005.02769.x Del Rosso, 2007, The randomized phase clinical trials evaluating antiinflammatory dose doxyciclyne administered once daily for treatment of rosacea, J Am Acad Dermatol, 56, 791, 10.1016/j.jaad.2006.11.021 Ionescu, 2009, Melanocytes dendricity down-regulated by the association of niacinamide-ascorbic acid, J Am Acad Dermatol, 60 Iglesias, 2008, Patologías de la mucosa oral, 223 Hunter, 1987, Clorhexidine gluconate mouthwash in the management in minor aphtous ulceration: a double-blind placebo-controlled cross-over trial, Br Dent J, 162, 106, 10.1038/sj.bdj.4806042 Gorsky, 2007, Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study, Dermatol Online J, 13, 1, 10.5070/D31658K5FQ Rattan, 1994, Sucralfate suspension as a treatment of recurrent aphthous stomatitis, J Intern Med, 236, 341, 10.1111/j.1365-2796.1994.tb00805.x Lee, 2007, The efficacy of topical 0,2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behcet́s disease, J Eur Acad Dermatol Venereol, 17, 7 Nolan, 2006, The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration, J Oral Pathol Med, 35, 461, 10.1111/j.1600-0714.2006.00433.x Langtry, 1992, Topical tretinoin: a new treatment for black hairy tongue (lingua villosa nigra), Clin Exp Dermatol, 17, 163, 10.1111/j.1365-2230.1992.tb00195.x Carbone, 2009, Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations, J Oral Pathol Med, 38, 227, 10.1111/j.1600-0714.2008.00688.x Cribier, 1998, Treatment of lichen planus. An evidence-Based Medicine Analysis of Efficacy, Arch Dermatol, 134, 1521, 10.1001/archderm.134.12.1521 Al Johani, 2009, Calcineurin inhibitors in oral medicine, J Am Acad Dermatol, 61, 829, 10.1016/j.jaad.2009.03.012 Choonhakarn, 2008, The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomised controlled trial, Br J Dermatol, 158, 573, 10.1111/j.1365-2133.2007.08370.x Salazar-Sánchez, 2010, Efficacy of topical Aloe vera in patients with oral lichen planus: a randomized double-blind study, J Oral Pathol Med, 39, 735, 10.1111/j.1600-0714.2010.00947.x Mansourian, 2011, Comparison of aloe vera mouthwash with triamcinolone acetonide 0,1% on oral lichen planus: a randomised double-blinded clinical trial, Am J Med Sci, 342, 447, 10.1097/MAJ.0b013e3182171164 Sharquie, 2006, Oral zinc sulfate in the treatment of Behçet's disease: a double blind cross-over study, J Dermatol, 33, 541, 10.1111/j.1346-8138.2006.00128.x Khalifa, 2008, The therapeutic and prophilactic role of oral zinc sulfate in management of recurrent aphthous stomatitis in comparison with dapsone, Saudi Med J, 29, 734 Scheinfeld, 2004, Levamisole in dermatology: a review, Am J Clin Dermatol, 5, 97, 10.2165/00128071-200405020-00004 Lynde, 2009, Successful treatment of complex aphthosis with colchicine and dapsone, Arch Dermatol, 145, 273, 10.1001/archdermatol.2008.591 Preshaw, 2007, Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: a pilot study, J Oral Pathol Med, 36, 236, 10.1111/j.1600-0714.2007.00507.x Rogers, 2008, Medical treatments for male and female pattern hair loss, J Am Acad Dermatol, 59, 547, 10.1016/j.jaad.2008.07.001 Rivera, 2008, Manejo de la alopecia androgenética en mujeres posmenopáusicas, Actas Dermosifiliogr, 99, 257, 10.1016/S0001-7310(08)74673-8 Camacho-Martínez, 2009, Hair loss in women, Semin Cutan Med Surg, 28, 19, 10.1016/j.sder.2009.01.001 Shin, 2007, Efficacy of 5% minoxidil versus combined 5% minoxidil and 0,01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial, Am J Clin Dermatol, 8, 285, 10.2165/00128071-200708050-00003 Georgala, 2004, Topical estrogen therapy for androgenetic alopecia in menopausal females, Dermatology, 208, 178, 10.1159/000076497 Blume-Peytavi, 2012, A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0,1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia, J Am Acad Dermatol, 66, 794, 10.1016/j.jaad.2011.05.026 Trueb, 2004, Swiss Trichology Study Group. Finasteride treatment of patterned hair los in normoandrogenic postmenopausal women, Dermatology, 209, 202, 10.1159/000079890 Iorizzo, 2006, Finasterida treatment of female pattern hair loss, Arch Dermatol, 142, 298, 10.1001/archderm.142.3.298 Garg, 2009, Alopecia areata: Evidence-based treatments, Semin Cutan Med Surg, 28, 15, 10.1016/j.sder.2008.12.002 Martínez, 2009, Tratamiento de la alopecia areata (i). Tratamientos locales, Piel, 24, 212, 10.1016/S0213-9251(09)70758-0 Fiedler-Weiss, 1987, Evaluation of anthralin in the treatment of alopecia areata, Arch Dermatol, 123, 1491, 10.1001/archderm.1987.01660350091020 Alkhalifah, 2010, Alopecia areata update Part II. Treatment, J Am Acad Dermatol, 62, 191, 10.1016/j.jaad.2009.10.031 Tosti, 2003, Clobetasol propionate 0,05% under occlusion in the treatment of alopecia totalis/universalis, J Am Acad Dermatol, 49, 96, 10.1067/mjd.2003.423 Ranchoff, 1989, Extensive alopecia areata. Results of treatment with 3% topical minoxidil, Cleve Clin J Med, 56, 149, 10.3949/ccjm.56.2.149 Fiedler-Weis, 1987, Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata, J Am Acad Dermatol, 16, 745, 10.1016/S0190-9622(87)80003-8 Ojeda, 2010, Bimatoprost in the treatment of eyelashes alopecia in alopecia areata universalis, Int J Trichol, 2, 86, 10.4103/0974-7753.77511 Coronel-Pérez, 2010, Latanoprost in the treatment of eyelashes alopecia in alopecia areata universalis, J Eur Acad Dermatol Venereol, 24, 481, 10.1111/j.1468-3083.2009.03543.x Avgerinou, 2008, Alopecia areata: topical immunotherapy treatment with diphencyprone, J Eur Acad Dermatol Venereol, 22, 320, 10.1111/j.1468-3083.2007.02411.x Mohamed, 2005, Alopecia areata treatment with a phototoxic dose of UVA and topical 8 methoxipsoralen, J Eur Acad Dermatol Venereol, 19, 552, 10.1111/j.1468-3083.2005.01226.x Taylor, 1995, PUVA treatment of alopecia areata partialis, totalis and universalis: Audit of 10 years experience at St Johńs Institute of Dermatology, Br J Dermatol, 133, 914, 10.1111/j.1365-2133.1995.tb06925.x Behrens-Williams, 2001, The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alpecia areata, J Am Acad Dermatol, 44, 248, 10.1067/mjd.2001.110060 Park, 2009, The therapeutic effect and the changed serum zinc level after zinc supplementation in alopecia areata patients who had a low serum zinc level, Ann Dermatol, 21, 142, 10.5021/ad.2009.21.2.142